Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03410238 · ClinicalTrials.gov registry record · NA
Saferteens in Primary Care
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03410238 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 110 participants.
The verdict
NCT03410238, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The SafERteens Study demonstrated the efficacy of a brief intervention (BI) for violence on changing attitudes, self-efficacy, and reducing violent behaviors, peer victimization, and violence-related consequences among adolescents in the emergency department (ED). Using a RE-AIM framework to measure outcomes (Reach, Effectiveness, Adoption, Implementation, and Maintenance), a study was conducted to translate this BI for violence into clinical practice in the ED. A SafERteens Implementation Package was created, which is housed on a website (www.saferteens.org), and includes: 1) a self-administered screen via iPad; 2) training materials (e.g., standardized patient videos); 3) clinician tools to guide intervention delivery; and 4) a tailored text message booster program. To increase reach and impact on reducing youth violence, this project will implement SafERteens into primary care. Primary care represents a logical dissemination channel for the SafERteens intervention because 95% of adolescents report having a usual place for primary health care, with 75% receiving medical care in the past six months. Violence interventions have yet to be systematically implemented in primary care settings despite the alarming prevalence of violent behaviors among adolescents.
Interventions
- BEHAVIORAL Saferteens Brief Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-06-07 |
| Est. Completion | 2019-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03410238
The ClinicalTrials.gov registry entry for NCT03410238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saferteens Brief Intervention is the first listed.
NCT03410238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03410238 about?
NCT03410238 is a clinical study titled "Saferteens in Primary Care". The SafERteens Study demonstrated the efficacy of a brief intervention (BI) for violence on changing attitudes, self-efficacy, and reducing violent behaviors, peer victimization, and violence-related consequences among adolescents in the emergency department (ED). Using a RE-AIM framework to measure...
What is the current status of trial NCT03410238?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2018-06-07. Estimated completion is 2019-11-15.
What interventions are being tested in trial NCT03410238?
The interventions under investigation include: Saferteens Brief Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03410238?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.